Frankfurt
03.11.26 | 08:09
59,50 Euro
+3,48 % +2,00
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 62,00 | 64,00 | 17:41 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:23 | Utah Medical Products erhöht Quartalsdividende um 1,6 % | 3 | Investing.com Deutsch | ||
| 16:19 | Utah Medical Products raises quarterly dividend by 1.6% | 3 | Investing.com | ||
| UTAH MEDICAL PRODUCTS Aktie jetzt für 0€ handeln | |||||
| 16:12 | Utah Medical Products raises dividend by 1.6% to $0.315 | 2 | Seeking Alpha | ||
| 16:02 | Utah Medical Products, Inc. Increases Quarterly Dividend | 168 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / November 3, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has approved a quarterly cash dividend of thirty-one and one-half... ► Artikel lesen | |
| Do | Utah Medical Products, Inc. Reports Corrected Results of Tender Offer | 307 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / October 29, 2026 / On September 24, Utah Medical Products, Inc. (Nasdaq:UTMD) offered to purchase up to 650,000 shares of its common stock at $75.00 per share.... ► Artikel lesen | |
| Do | Utah Medical Products, Inc. Reports Results of Tender Offer | 337 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / October 29, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) offered to purchase up to 650,000 shares of its common stock at $75.00 per share. The issuer Tender... ► Artikel lesen | |
| 23.10. | Utah Medical Products GAAP EPS of $0.87, revenue of $8.62M | 2 | Seeking Alpha | ||
| 22.10. | UTAH MEDICAL PRODUCTS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 22.10. | Utah Medical Products, Inc.: UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026 | 305 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / October 22, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2026 financial results that... ► Artikel lesen | |
| 05.10. | Dividendenbekanntmachungen (05.10.2026) | 10.590 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMA GROUP LIMITED AU000000AMA8 0,005 AUD EUR AMERIS BANCORP US03076K1088 0,2 USD EUR ASMODEE GROUP AB SE0023615638 - EUR ASX... ► Artikel lesen | |
| 05.10. | Utah Medical Products, Inc. Extends Tender Offer | 509 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was... ► Artikel lesen | |
| 25.09. | Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date | 550 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions... ► Artikel lesen | |
| 24.09. | Utah Medical bietet Aktienrückkauf zu 75 US-Dollar je Aktie an | 3 | Investing.com Deutsch | ||
| 24.09. | Utah Medical offers to buy back shares at $75 premium | 2 | Investing.com | ||
| 24.09. | Utah Medical Products, Inc. Commences Tender Offer | 603 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / September 24, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The $75.00... ► Artikel lesen | |
| 17.09. | Dividendenbekanntmachungen (17.09.2026) | 9.432 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,095 NZD 0,0473 EUR AXFOOD AB SE0006993770 4,5 SEK 0,398 EUR BEST BUY CO INC US0865161014 0... ► Artikel lesen | |
| 15.09. | Utah Medical Products startet Rückkaufangebot für 75 US-Dollar pro Aktie | 6 | Investing.com Deutsch | ||
| 15.09. | Utah Medical Products launches tender offer at $75 per share | 1 | Investing.com | ||
| 15.09. | Utah Medical Products, Inc.: UTMD Announces Self-Tender for 20% of Its Shares | 656 | ACCESS Newswire | SALT LAKE CITY, UT / ACCESS Newswire / September 15, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its... ► Artikel lesen | |
| 31.08. | UTAH MEDICAL PRODUCTS INC - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 35,000 | +0,46 % | Carl Zeiss Meditec, Drägerwerk und Sartorius: Drägerwerk führt, Sartorius folgt, Carl Zeiss Meditec hängt zurück | ||
| ECKERT & ZIEGLER | 13,390 | -0,59 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225
28.10.2026 / 14:00 CET/CEST
Für den... ► Artikel lesen | |
| ESSILORLUXOTTICA | 184,25 | -1,94 % | 7,49 Milliarden Euro Quartalsumsatz: Was EssilorLuxotticas Wachstum über das Geschäft mit moderner Optik verrät | ||
| EUROFINS SCIENTIFIC | 87,44 | +0,21 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| STRAUMANN | 109,95 | +0,78 % | Adhoc: Straumann Holding AG: Straumann Group beschleunigt organisches Wachstum auf 9.2% und bestätigt Ausblick für das Gesamtjahr 2026 | Straumann Holding AG / Schlagwort(e): Quartalsergebnis
Straumann Group beschleunigt organisches Wachstum auf 9.2% und bestätigt Ausblick für das Gesamtjahr 2026 28.10.2026 / 07:00 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| TECAN GROUP | 267,80 | +0,53 % | Tecan Group AG: Tecan to participate in upcoming Investor Conference | Männedorf, Switzerland, September 10, 2026 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will participate in the following investor conference next week:
24th Annual Morgan... ► Artikel lesen | |
| CAREDX | 79,00 | +2,60 % | CareDx study links early kidney transplant monitoring to outcomes | ||
| ACCENDRA HEALTH | 0,222 | -7,50 % | Accendra Health, Inc. Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard | RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 27, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE")... ► Artikel lesen | |
| LIVANOVA | 71,00 | -1,39 % | LivaNova PLC: Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova's VNS Therapy for Drug-Resistant Epilepsy | CORE-VNS is the largest prospective, multinational observational study evaluating contemporary VNS Therapy devices in people with Drug-Resistant Epilepsy
- Demonstrated 76% median reduction in seizure... ► Artikel lesen | |
| ESTABLISHMENT LABS | 54,80 | +0,29 % | Mizuho reiterates Establishment Labs stock rating on strong sales | ||
| ASTRANA HEALTH | 33,000 | 0,00 % | Astrana Health, Inc. Reports Second Quarter 2026 Results | Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ET
Reports revenue of $972.5 million, up 49% year-over-year, net income... ► Artikel lesen | |
| SONIDA SENIOR LIVING | 30,000 | 0,00 % | Biotech Stocks At 52-Week Highs - Labcorp Holdings Rises With Genetic Testing Launch, Dyne Therapeutics, Sonida Senior Living, Silence Therapeutics, Amylyx Pharmaceuticals | LONDON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 27, 2026, driven by key catalysts including prospective clinical trial results, and the launch of new services.Dyne... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,760 | -4,30 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für FMC mit einem Kursziel von 36 Euro auf "Sell" belassen. Der Gegenwind für die Gewinnentwicklung im Jahr 2027 nehme zu, schrieb... ► Artikel lesen | |
| FRESENIUS | 48,920 | +0,70 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Die Aktie steht zudem auf der "Analyst Focus List" der US-Bank. Die Anlagestory des... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,330 | -0,16 % | Siemens Healthineers steht vor einer wichtigen Bewährungsprobe | Siemens Healthineers nähert sich einem entscheidenden Moment. Nach einer längeren Phase der Unsicherheit hat sich die Aktie zuletzt erholt, doch operativ bleibt der Medizintechnikkonzern ein Unternehmen... ► Artikel lesen |
UTAH MEDICAL PRODUCTS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +2,00 (+3,48 %) liegt der Kurs bei 59,50 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UTAH MEDICAL PRODUCTS INC finden Sie auf Wallstreet Online.